Surmodics Statistics
Total Valuation
Surmodics has a market cap or net worth of $498.22 million. The enterprise value is $501.10 million.
Important Dates
The last earnings date was Thursday, January 30, 2025, before market open.
| Earnings Date | Jan 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Surmodics has 14.30 million shares outstanding. The number of shares has increased by 0.89% in one year.
| Current Share Class | 14.30M |
| Shares Outstanding | 14.30M |
| Shares Change (YoY) | +0.89% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 4.03% |
| Owned by Institutions (%) | 73.00% |
| Float | 13.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.94 |
| Forward PS | n/a |
| PB Ratio | 4.46 |
| P/TBV Ratio | 10.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 434.74 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.99 |
| EV / EBITDA | 75.47 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.45, with a Debt / Equity ratio of 0.30.
| Current Ratio | 5.45 |
| Quick Ratio | 4.00 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 3.98 |
| Debt / FCF | n/a |
| Interest Coverage | -0.51 |
Financial Efficiency
Return on equity (ROE) is -12.32% and return on invested capital (ROIC) is -0.75%.
| Return on Equity (ROE) | -12.32% |
| Return on Assets (ROA) | -0.66% |
| Return on Invested Capital (ROIC) | -0.75% |
| Return on Capital Employed (ROCE) | -1.20% |
| Revenue Per Employee | $322,488 |
| Profits Per Employee | -$37,036 |
| Employee Count | 389 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 2.15 |
Taxes
In the past 12 months, Surmodics has paid $4.68 million in taxes.
| Income Tax | 4.68M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.39% in the last 52 weeks. The beta is 1.20, so Surmodics's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | +10.39% |
| 50-Day Moving Average | 37.24 |
| 200-Day Moving Average | 38.82 |
| Relative Strength Index (RSI) | 44.29 |
| Average Volume (20 Days) | 284,345 |
Short Selling Information
The latest short interest is 601,743, so 4.21% of the outstanding shares have been sold short.
| Short Interest | 601,743 |
| Short Previous Month | 462,812 |
| Short % of Shares Out | 4.21% |
| Short % of Float | 4.62% |
| Short Ratio (days to cover) | 1.79 |
Income Statement
In the last 12 months, Surmodics had revenue of $125.45 million and -$14.41 million in losses. Loss per share was -$1.02.
| Revenue | 125.45M |
| Gross Profit | 93.52M |
| Operating Income | -1.80M |
| Pretax Income | -9.16M |
| Net Income | -14.41M |
| EBITDA | 6.64M |
| EBIT | -1.80M |
| Loss Per Share | -$1.02 |
Full Income StatementBalance Sheet
The company has $30.15 million in cash and $33.03 million in debt, giving a net cash position of -$2.88 million or -$0.20 per share.
| Cash & Cash Equivalents | 30.15M |
| Total Debt | 33.03M |
| Net Cash | -2.88M |
| Net Cash Per Share | -$0.20 |
| Equity (Book Value) | 111.77M |
| Book Value Per Share | 7.82 |
| Working Capital | 58.66M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.15 million and capital expenditures -$3.07 million, giving a free cash flow of -$1.93 million.
| Operating Cash Flow | 1.15M |
| Capital Expenditures | -3.07M |
| Free Cash Flow | -1.93M |
| FCF Per Share | -$0.13 |
Full Cash Flow StatementMargins
Gross margin is 74.55%, with operating and profit margins of -1.44% and -11.48%.
| Gross Margin | 74.55% |
| Operating Margin | -1.44% |
| Pretax Margin | -7.75% |
| Profit Margin | -11.48% |
| EBITDA Margin | 5.29% |
| EBIT Margin | -1.44% |
| FCF Margin | n/a |
Dividends & Yields
Surmodics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.89% |
| Shareholder Yield | -0.89% |
| Earnings Yield | -2.89% |
| FCF Yield | -0.39% |
Analyst Forecast
The average price target for Surmodics is $43.00, which is 23.39% higher than the current price. The consensus rating is "Hold".
| Price Target | $43.00 |
| Price Target Difference | 23.39% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on December 7, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 7, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Surmodics has an Altman Z-Score of 7.77 and a Piotroski F-Score of 4.
| Altman Z-Score | 7.77 |
| Piotroski F-Score | 4 |